KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Biolife Solutions (BLFS) Notes Payables (2016)

Biolife Solutions (BLFS) has disclosed Notes Payables for 1 consecutive years, with $2.8 million as the latest value for Q4 2016.

On a quarterly basis, Notes Payables changed N/A to $2.8 million in Q4 2016 year-over-year; TTM through Dec 2016 was $2.8 million, a N/A change, with the full-year FY2016 number at $2.8 million, changed N/A from a year prior.
Notes Payables was $2.8 million for Q4 2016 at Biolife Solutions, up from $1.8 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $2.8 million in Q4 2016 to a low of $656809.0 in Q2 2016.